Fluctuation of BCR-ABL1 qPCRIS level beyond 0.1%IS after stopping tyrosine kinase inhibitor in chronic myeloid leukaemia patients with deep molecular response for at least two years
Fluctuation of BCR-ABL1 real-time quantitative polymerase chain reaction in International Scale (qPCRIS ) level below major molecular response (MMR) (0.1%IS ) is a known phenomenon after stopping tyrosine kinase inhibitor (TKI) in chronic myeloid leukaemia (CML) patients who are attempting tr...
Saved in:
Main Authors: | Kuan, Jew-Win, Chang, Kian-Meng, Chin, Lee Phan, Wong, Shu Ping, Lim, Soo Min, Toh, See Guan, Loh, Weng Khean |
---|---|
Format: | Article |
Language: | English |
Published: |
NCBI Literature Resources
2021
|
Subjects: | |
Online Access: | http://ir.unimas.my/id/eprint/37246/1/myeloid1.pdf http://ir.unimas.my/id/eprint/37246/ https://pubmed.ncbi.nlm.nih.gov/34031342/ |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Higher prevalence of harbouring BCR::ABL1 in first-degree relatives of chronic myeloid leukaemia (CML) patients compared to normal population
by: Kuan, Jew Win, et al.
Published: (2024) -
Philadelphia chromosome and FISH- negative, cryptic BCR/ABL1 positive acute myeloid leukaemia: A diagnostic dilemma
by: Abdul Halim, Sarah, et al.
Published: (2022) -
The magnitude of tyrosine kinase inhibitor induced cytopaenia on normal haematopoietic tissues in chronic myeloid leukaemia patients
by: Jew Win, Kuan, et al.
Published: (2022) -
Aleukemic bcr-abl positive granulocytic sarcoma
by: Kuan, Jew-Win, et al.
Published: (2009) -
Systematic Review of Normal Subjects Harbouring BCR-ABL1 Fusion Gene
by: Kuan, Jew-Win, et al.
Published: (2019)